Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T-cell receptor beta variable 7-9 (TRBV7-9)
- Target
- TRBV7-9
- Molecular classification
- Immunoglobulin superfamily, T-cell receptor gene segment, Variable region
01
Overview
The T-cell receptor beta variable 7-9 (TRBV7-9) is one of many gene segments coding for the variable region of the beta chain of the T-cell receptor. TCRs are heterodimers on T lymphocytes, most commonly composed of an alpha (TRA) and beta (TRB) chain, which together recognize antigenic peptides presented by major histocompatibility complex (MHC) molecules. Diversity in antigen specificity is achieved through somatic V(D)J recombination of various gene segments, where TRBV7-9 is one such beta variable segment. While the full TCR is critical for T-cell-mediated immunity and is a focus in immunotherapy, individual variable region gene segments like TRBV7-9 are genomic building blocks, not discrete protein targets, and are not therapeutic targets themselves[1][2].
- Other names
- TRBV7-9TCRBV07-09TCR beta V7-9
02
Mechanism of action
null
03
Biological functions
Antigen recognition specificity (as a part of full TCR heterodimer)Contributes to immune diversity
04
Disease associations
Other (changes in TCR variable region usage can be associated with immune diseases, leukemia, or infection, but the TRBV7-9 segment itself is not commonly a direct disease target)
05
Biomarkers
Changes in TCR beta repertoire (including some variable segment usage, like TRBV7-9) may serve as immunological biomarkers in some disease contexts, but TRBV7-9 is not a validated general biomarker
Beyond the preview
Go deeper on T-cell receptor beta variable 7-9 (TRBV7-9).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on T-cell receptor beta variable 7-9 (TRBV7-9).